UBS initiated coverage on Tata Motors’ commercial vehicles business with a buy rating and a ₹550 price target, citing undervaluation compared to global peers. The brokerage also reiterated a buy on Ashok Leyland, raising its price target to ₹225. UBS believes Indian CV makers are poised to narrow valuation gaps due to improving fundamentals.
Health insurers rise after US lifts 2027 Medicare Advantage payment rates
U.S. health insurer stocks surged after the government announced higher-than-expected Medicare Advantage payment rates for 2027, unlocking over $13 billion in additional payouts. The move